Impact News +++ Ambu shares sink 13% as tariffs and currency costs bite into margins (Investing.com) +++ AMBU Aktie -3,05%

HEALTHEQUITY Aktie

>HEALTHEQUITY Aktienkurs

83 EUR (Tradegate)

Ask: 84 EUR / 120 Stück

Bid: 82 EUR / 123 Stück

Tagesumsatz: 0 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

HEALTHEQUITY Aktie über LYNX handeln

Intraday

1 Jahr

>HEALTHEQUITY Performance

1 Woche: 0%

1 Monat: +7,2%

3 Monate: +3,5%

6 Monate: +1,9%

1 Jahr: +1,9%

laufendes Jahr: -10,9%

>HEALTHEQUITY Aktie

Name:

HEALTHEQUITY INC.DL-,0001

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US42226A1079 / A119D1

Symbol/ Ticker:

2HE (Frankfurt) / HQY (NASDAQ)

Kürzel:

FRA:2HE, ETR:2HE, 2HE:GR, NASDAQ:HQY

Index:

Webseite:

https://www.healthequity...

Profil:

HealthEquity Inc. is a prominent player in the hea..
>Volltext..

Marktkapitalisierung:

7108.96 Mio. EUR

Unternehmenswert:

7768 Mio. EUR

Umsatz:

1104.34 Mio. EUR

EBITDA:

398.52 Mio. EUR

Nettogewinn:

126.92 Mio. EUR

Gewinn je Aktie:

1.46 EUR

Schulden:

918.18 Mio. EUR

Liquide Mittel:

264.97 Mio. EUR

Operativer Cashflow:

319.31 Mio. EUR

Bargeldquote:

2.61

Umsatzwachstum:

9.49%

Gewinnwachstum:

30.88%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

2 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 295.207 USD.

Suchwörter:

HEALTHEQUITY

Letzte Datenerhebung:

05.11.25

>HEALTHEQUITY Kennzahlen

Aktien/ Unternehmen:

Aktien: 86.16 Mio. St.

Frei handelbar: 97.75%

Leerverk. Aktien: 4.92%

Rückkaufquote: 2.84%

Mitarbeiter: 3120

Umsatz/Mitarb.: 0.33 Mio. EUR

Analysten:

Analystenrating: Strong buy

Kursziel: 25.34%

Bewertung:

KGV: 57.36

KGV lG: 24.58

KUV: 6.49

KBV: 3.82

PEG-Ratio: 1.51

EV/EBITDA: 19.49

Rentabilität:

Bruttomarge: 59.96%

Gewinnmarge: 11.49%

Operative Marge: 23.71%

Managementeffizenz:

Gesamtkaprendite: 4.21%

Eigenkaprendite: 6.78%

>HEALTHEQUITY Peer Group

Es sind 597 Aktien bekannt.

>HEALTHEQUITY Chart & Kurs - NASDAQ

>HEALTHEQUITY News

23.10.25 - 02:02	Insiderhandel: EVP, General Counsel verkauft Aktien von HealthEquity im Wert von 138105 USD (Insiderkauf)
	Ladd, Delano - Vorstand - Tag der Transaktion: 2025-10-20...

20.10.25 - 17:30	HQY Expands Access With GLP-1 Telehealth & Direct HSA Platforms (Zacks)
	HealthEquity rolls out GLP-1 telehealth and direct HSA enrollment platforms, targeting affordability and growth amid rising healthcare costs and regulatory expansion....

17.10.25 - 17:30	Here′s Why HealthEquity (HQY) is a Strong Growth Stock (Zacks)
	The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage....

16.10.25 - 20:30	Reasons to Add HealthEquity Stock to Your Portfolio for Now (Zacks)
	HQY's strong Q2, expanding HSAs and AI-driven efficiencies highlight its growth momentum despite data security risks....

14.10.25 - 15:12	HealthEquity launches GLP-1 telehealth platform (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

09.10.25 - 00:01	Insiderhandel: EVP, CHIEF COMMERCIAL OFFICER verkauft Aktien von HealthEquity im Wert von 157102 USD (Insiderkauf)
	Fiore, Michael Henry - Vorstand - Tag der Transaktion: 2025-10-07...

02.10.25 - 19:00	HealthEquity (HQY) Down 5.1% Since Last Earnings Report: Can It Rebound? (Zacks)
	HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues....

26.09.25 - 18:15	Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term (Zacks)
	The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage....

25.09.25 - 15:03	HealthEquity Strengthens Executive Leadership Team with Strategic Appointments to Drive Growth and Innovation (GlobeNewswire EN)
	New CMO and Sales Executive Join from Mastercard and EverQuote to Capitalize on Historic HSA Market Expansion New CMO and Sales Executive Join from Mastercard and EverQuote to Capitalize on Historic HSA Market Expansion...

23.09.25 - 17:30	Why HealthEquity (HQY) is a Top Momentum Stock for the Long-Term (Zacks)
	Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service....

23.09.25 - 05:01	Insiderhandel: EVP, General Counsel verkauft Aktien von HealthEquity im Wert von 564648 USD (Insiderkauf)
	Ladd, Delano - Vorstand - Tag der Transaktion: 2025-09-19...

10.09.25 - 00:01	Insiderhandel: Aufsichtsrat verkauft Aktien von HealthEquity im Wert von 322916 USD (Insiderkauf)
	Dilsaver, Evelyn S. - Aufsichtsrat - Tag der Transaktion: 2025-09-05...

09.09.25 - 17:30	Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term (Zacks)
	The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage....

04.09.25 - 22:48

Miran Touts Fed Independence at Confirmation Hearing | Bloomberg Businessweek Daily 9/4/2025 (Bloomberg)

On today's episode of Bloomberg Businessweek Daily, Carol Massar and Tim Stenovec discuss Stephen Miran's confirmation hearing to become a Federal Reserve Governor. Bloomberg's Michael McKee joins to break down Miran's assertion he intends to preserve Fed independence. Also on today's show, Liberty Global Chairman John Malone sits down with David Gura, Affirm Chief Executive Officer Max Levchin talks the Buy Now, Pay Later boom, and HealthEquity Chief Executive Officer Scott Cutler highlights the growth of the HSA market. (Source: Bloomberg)...

03.09.25 - 21:15	HealthEquity Stock Gains as Q2 Earnings Beat Estimates, Revenues Up Y/Y (Zacks)
	HQY's Q2 results reflect EPS growth of 25.6% year over year, revenue growth of 8.6% and a 12% increase in HSA. The company also updates its fiscal 2026 guidance....

03.09.25 - 14:36	HealthEquity Net Income Jumps 67% in Q2 (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

03.09.25 - 11:09	HealthEquity stock gains as FY 2026 guidance rises, AI and HSA expansion advance (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

03.09.25 - 01:42	HealthEquity raises fiscal 2026 guidance to $1.31B revenue and $3.91 EPS while advancing AI service and HSA market expansion (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

03.09.25 - 01:00	Compared to Estimates, HealthEquity (HQY) Q2 Earnings: A Look at Key Metrics (Zacks)
	Although the revenue and EPS for HealthEquity (HQY) give a sense of how its business performed in the quarter ended July 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers....

03.09.25 - 01:00	HealthEquity (HQY) Q2 Earnings and Revenues Surpass Estimates (Zacks)
	HealthEquity (HQY) delivered earnings and revenue surprises of +17.39% and +2.20%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Die Sprache des Baus braucht man manchmal auch im Management. - Mag. Dr. Martin Kriegner

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram